U.S. budget cuts could impact drug development for TB, HIV/AIDS

Kaitlin Christenson Read More »

Illinois no longer experiencing widespread flu

Influenza levels in Illinois are no longer widespread, which may signal that the worst is over for the earlier-than-expected flu season, according to recent data from the Centers for Disease Control and Prevention. Read More »

Australian researchers begin human trials on Streptococcus A vaccine

Streptococcus Read More »

Bacteriophage shown to take over cholera's immune system

Cholera Read More »

FDA panel approves four-strain flu vaccines

A U.S. Food and Drug Administration advisory panel on vaccines gave its approval on Wednesday to quadrivalent, or four-strain, flu vaccines that may over time replace current three-strain vaccines. Read More »

NIH scientists attempt to understand deadly new coronavirus

Scientists at the U.S. National Institutes of Health are attempting to find out more about a lethal new coronavirus and determine if it will become a pandemic or stay a limited threat. Read More »

Measles outbreak hits Wales, 190 infections confirmed since November

Measles Read More »

San Diego public health officials record two additional flu deaths

Influenza Read More »

Gates: We can end polio

Bill Gates Read More »

Viruses possess multiple qualities associated with complex lifeforms

Andrew Camilli Read More »

Influenza virus infectiousness heavily affected by indoor humidity

Influenza Read More »

Tennessee lawmakers sponsor meningitis requirement for public universities

Lowe Finney Read More »

U.K. whooping cough cases drop

Whooping cough Read More »

Agenus finishes patient enrollment in herpes vaccine trial

Agenus, Inc., a Lexington, Massachusetts-based therapeutic vaccine developer, announced on Friday that it has completed the patient screening in a Phase II trial for HerpV, its genital herpes vaccine candidate. Read More »

Pakistani officer fatally shot while guarding polio workers

Polio Read More »

Cambodia identifies ninth case of H5N1 in 2013

H5N1 Read More »

Keryx posts 12 percent gain on GSK acquisition talk

Keryx Biopharmaceuticals, Inc., a New York based biotechnology company, gained $0.76 to $7.19 on Friday following media reports that GlaxoSmithKline, Plc, is considering an acquisition of the biotech. Read More »

Sarepta announces positive results in Marburg virus therapeutic study

Sarepta Therapeutics, Inc., a Cambridge, Massachusetts-based developer of RNA-based therapeutics, announced positive results on Monday from a non-human primate study of the company's lead drug candidate for treating Marburg virus infection. Read More »

Burundi officially adds second dose of measles vaccine to national schedule

Burundi officially introduced the second dose of the measles vaccine into its national immunization program during its recent 2013 mother-child health week. Read More »

Nigeria state more than doubles polio vaccination teams for upcoming campaign

Polio Read More »